miR-4270抑制对肝细胞癌细胞系 (HepG2) 迁移的影响
Hassan Akrami1, Hanieh Gholami1, Mohammad Reza Fattahi1
1Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Iranian biomedical journal
|July 10, 2023
概括
在肝细胞癌 (HCC) 细胞中抑制miR-4270减少了它们的迁移和矩阵金属蛋白酶 (MMP) 活性. 这表明miR-4270抑制剂可能是抑制HCC转移的新策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肝细胞癌 (HCC) 是一个主要的全球健康问题.
- 肝移植和手术切除是HCC的主要治疗方式.
- 抑制HCC转移对于改善患者的治疗结果至关重要.
研究的目的:
- 研究miR-4270抑制剂对HepG2细胞迁移的影响.
- 评估miR-4270抑制对HCC细胞中矩阵金属蛋白酶 (MMP) 活性的影响.
- 探索一种潜在的治疗策略来抑制HCC转移.
主要方法:
- 用不同度的miR-4270抑制剂治疗HepG2细胞.
- 细胞活力是通过试蓝色染色来确定的.
- 细胞迁移,MMP活性和MMP基因表达分别通过伤口愈合试验,生殖图和实时RT-PCR进行分析.
主要成果:
- miR-4270抑制剂以剂量依赖的方式降低了HepG2细胞活力.
- 抑制miR-4270显著降低了HepG2细胞入侵和MMP活性.
- 在miR-4270抑制后观察到MMP基因表达的下调.
结论:
- miR-4270的抑制有效地减少了HCC细胞的体外迁移.
- 这些发现表明miR-4270抑制剂可能为HCC患者提供一种新的治疗方法.
- 向miR-4270为抑制HCC转移提供了一个有希望的策略.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Cell Migration
4.9K
Cell migration is a process by which the cells move from one location to another, playing an essential role in embryological development, repair and regeneration, immune response, and metastasis. Cells migrate in response to chemical or mechanical signals generated by specific organs or tissues. The overall mechanism includes three steps - polarization, protrusion, and release. Polarization involves the formation of a distinct cell front and rear, which determines the direction of movement.
4.9K


